Description
Short Dated Product - CSI-CUP-255 - 5/31/25 - Price Reflects Discount
Five Panel CSI Drug Test Cup, CLIA Screen In-Vitro, CLIA Waived, 25/Box
This High Quality CLIA Waived drug test cup is an easy, fast, qualitative, competitive binding immunoassay method for screening without the need of instrumentation.
The best selling CSI Cup (CLIA Screen In-Vitro) Multi-Panel Drug Test Cup is a No Step, fully integrated self contained multi-drug screening cup. No tipping or turning required. Read results in 5 minutes. The cup is FDA Cleared and CLIA Waived. This cup is a fast visual, competitive panel immunoassay that can be used for the simultaneous, qualitative detection of multiple drug metabolites at specific cutoff levels in human urine.
Features & Benefits
- CLIA Waived
- FDA 510(K) Approved
- Sold in boxes of 25 tests
- "Click Seal" cap - when you hear the “CLICK” the cup is sealed and the specimen is secured
- No step cup
- Up to 99% Accurate
- Dual scale Temperature Strip verifies if urine is "fresh" and not diluted
- Adheres to the SAMHSA Cutoff Levels
- Immediate Results
- Shelf-life up to 24 months
- New easy to open top for the confirmation lab
Download & Print Reference Materials
CLIA Screen In Vitro Cup (CLIA Waived) Drug Test Package Insert
CLIA Screen In Vitro Cup (CLIA Waived) Drug Test Instruction Sheet
| Five Panel Configurations (choose panel above) | ||
|---|---|---|
| Item Number | Drugs Tested | Adulterants Tested |
| CSI-CUP-254 | AMP, COC, MET/mAMP, OPI, THC | None |
| CSI-CUP-255 | AMP, COC, MET/mAMP, MOP, THC | None |
| Urine Drug Panel Detection Table | ||||
| Drug Name | Abbreviation | Cutoff Level | Detection Time Range in Urine* | Calibrator |
| Amphetamine | AMP | 1000 ng/ml | 2-7 hours to 2-4 days | D-Amphetamine |
| Barbiturates | BAR | 300 ng/ml | 2-4 hours to 1-3 weeks | Secobarbital |
| Benzodiazepines | BZO / BZD | 300 ng/ml | 2-7 hours to 1-4 days | Benzoylecgonine |
| Buprenorphine | BUP | 10 ng/ml | 2-3 hours to 1 day | Buprenorphine |
| Cocaine | COC | 300 ng/ml | 1-4 hours to 2-4 days | Benzoylecgonine |
| Ecstasy | MDMA | 500 ng/ml | 1-3 days to 1-2 days | D,L-Methylenedioxy-methamphetamine |
| Marijuana | THC | 50 ng/ml | 2 hours to up to 40 days | 11-nor-Δ9-THC-9 COOH |
| Methadone | MTD / MAD | 300 ng/ml | 3-8 hours to 1-3 days | Methadone |
| Methamphetamine | mAMP / MET | 1000 ng/ml | 2-7 hours to 2-4 days | D-Methamphetamine |
| Morphine | MOP / OPI-300 | 300 ng/ml | 2 hours to 2-3 days | Morphine |
| Opiates | OPI | 2000 ng/ml | 2 hours to 2-3 days | Morphine |
| Oxycodone | OXY | 100 ng/ml | 1-3 hours to 1-2 days | Oxycodone |
| Phencyclidine | PCP | 25 ng/ml | 4-6 hours to 7-14 days | Phencyclidine |
| Propoxyphene | PPX | 300 ng/ml | 1-2 days | Propoxyphene |
| Tricyclic Antidepressants | TCA | 1000 ng/ml | 8-12 hours to 2-7 days | Nortriptyline |
| *Detection times are estimates and may vary. Refer to the configuration above for the specific drug panels included. This assay provides a preliminary analytical result. To confirm the result, a more specific chemical method, such as Gas Chromatography/Mass Spectrometry (GC/MS), should be used. Clinical judgment and professional evaluation are essential, especially when interpreting preliminary positive results. | ||||
